161 related articles for article (PubMed ID: 23105273)
1. Clinical and oncological significance of aberrant Fas (APO-1/CD95) isoform expression in adult T-cell leukemia.
Kamihira S; Yamada Y; Maeda T
Indian J Clin Biochem; 2000 Aug; 15(Suppl 1):101-9. PubMed ID: 23105273
[TBL] [Abstract][Full Text] [Related]
2. Soluble and membrane isoforms of Fas/CD95 in fresh adult T-cell leukemia (ATL) cells and ATL-cell lines.
Sugahara K; Yamada Y; Hiragata Y; Matsuo Y; Tsuruda K; Tomonaga M; Maeda T; Atogami S; Tsukasaki K; Kamihira S
Int J Cancer; 1997 Jul; 72(1):128-32. PubMed ID: 9212233
[TBL] [Abstract][Full Text] [Related]
3. Soluble Fas (APO-1/CD95) isoform in adult T-cell leukemia.
Kamihira S; Yamada Y
Leuk Lymphoma; 2001 Mar; 41(1-2):169-76. PubMed ID: 11342370
[TBL] [Abstract][Full Text] [Related]
4. Mutation of CD95 (Fas/Apo-1) gene in adult T-cell leukemia cells.
Tamiya S; Etoh K; Suzushima H; Takatsuki K; Matsuoka M
Blood; 1998 May; 91(10):3935-42. PubMed ID: 9573032
[TBL] [Abstract][Full Text] [Related]
5. Discrepant expression of membrane and soluble isoforms of Fas (CD95/APO-1) in adult T-cell leukaemia: soluble Fas isoform is an independent risk factor for prognosis.
Kamihira S; Yamada Y; Tomonaga M; Sugahara K; Tsuruda K
Br J Haematol; 1999 Dec; 107(4):851-60. PubMed ID: 10606894
[TBL] [Abstract][Full Text] [Related]
6. Fas gene mutation in the progression of adult T cell leukemia.
Maeda T; Yamada Y; Moriuchi R; Sugahara K; Tsuruda K; Joh T; Atogami S; Tsukasaki K; Tomonaga M; Kamihira S
J Exp Med; 1999 Apr; 189(7):1063-71. PubMed ID: 10190897
[TBL] [Abstract][Full Text] [Related]
7. Quantitative characterization and potential function of membrane Fas/APO-1 (CD95) receptors on leukaemic cells from chronic B and T lymphoid leukaemias.
Kamihira S; Yamada Y; Hirakata Y; Tsuruda K; Sugahara K; Tomonaga M; Maeda T; Tsukasaki K; Atogami S; Kobayashi N
Br J Haematol; 1997 Dec; 99(4):858-65. PubMed ID: 9432034
[TBL] [Abstract][Full Text] [Related]
8. Possible attenuation of fas-mediated signaling by dominant expression of caspase-8 aberrant isoform in adult T-cell leukemia cells.
Sugahara K; Hayashi T; Dateki N; Hirakata Y; Harasawa H; Tomonaga M; Yamada Y; Kamihira S
Int J Hematol; 2002 Jul; 76(1):50-4. PubMed ID: 12138895
[TBL] [Abstract][Full Text] [Related]
9. A genetic IFN/STAT1/FAS axis determines CD4 T stem cell memory levels and apoptosis in healthy controls and Adult T-cell Leukemia patients.
Khouri R; Silva-Santos G; Dierckx T; Menezes SM; Decanine D; Theys K; Silva AC; Farré L; Bittencourt A; Mangino M; Roederer M; Vandamme AM; Van Weyenbergh J
Oncoimmunology; 2018; 7(5):e1426423. PubMed ID: 29721391
[TBL] [Abstract][Full Text] [Related]
10. An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitro.
Papoff G; Cascino I; Eramo A; Starace G; Lynch DH; Ruberti G
J Immunol; 1996 Jun; 156(12):4622-30. PubMed ID: 8648105
[TBL] [Abstract][Full Text] [Related]
11. Soluble Fas/Apo-1 splicing variants and apoptosis.
Cascino I; Papoff G; Eramo A; Ruberti G
Front Biosci; 1996 Jan; 1():d12-8. PubMed ID: 9159204
[TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide induces apoptosis in HTLV-I infected T-cell lines and fresh adult T-cell leukemia cells through CD95 or tumor necrosis factor alpha receptor independent caspase activation.
Ishitsuka K; Ikeda R; Utsunomiya A; Uozumi K; Hanada S; Suzuki S; Takeuchi S; Takatsuka Y; Takeshita T; Ohno N; Arima T
Leuk Lymphoma; 2002 May; 43(5):1107-14. PubMed ID: 12148893
[TBL] [Abstract][Full Text] [Related]
13. [Fas antigen (CD95) expressions and apoptosis of neoplastic cells from various lymphoid malignancies including adult T-cell leukemia/lymphoma].
Sasao T; Yoshida M; Ichikawa Y
Nihon Rinsho; 1996 Jul; 54(7):1986-91. PubMed ID: 8741700
[TBL] [Abstract][Full Text] [Related]
14. Modulation of resistance to anti-APO-1-induced apoptosis in osteosarcoma cells by cytokines.
Fellenberg J; Mau H; Scheuerpflug C; Ewerbeck V; Debatin KM
Int J Cancer; 1997 Jul; 72(3):536-42. PubMed ID: 9247301
[TBL] [Abstract][Full Text] [Related]
15. Fas 670 promoter polymorphism is associated to susceptibility, clinical presentation, and survival in adult T cell leukemia.
Farre L; Bittencourt AL; Silva-Santos G; Almeida A; Silva AC; Decanine D; Soares GM; Alcantara LC; Van Dooren S; Galvão-Castro B; Vandamme AM; Van Weyenbergh J
J Leukoc Biol; 2008 Jan; 83(1):220-2. PubMed ID: 17962369
[TBL] [Abstract][Full Text] [Related]
16. Frequent deletion of Fas gene sequences encoding death and transmembrane domains in nasal natural killer/T-cell lymphoma.
Shen L; Liang AC; Lu L; Au WY; Kwong YL; Liang RH; Srivastava G
Am J Pathol; 2002 Dec; 161(6):2123-31. PubMed ID: 12466128
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of soluble Fas/APO-1 receptor in human retroviral infection and associated diseases.
Kamihira S; Yamada Y; Hiragata Y; Yamaguchi T; Izumikawa K; Matsuo Y; Sugahara K; Tsuruta K; Atogami S; Tsukasaki K; Maeda T; Tomonaga M
Intern Med; 1997 Mar; 36(3):166-70. PubMed ID: 9144006
[TBL] [Abstract][Full Text] [Related]
18. CD95 (APO-1/FAS) deficiency in infant acute lymphoblastic leukemia: detection of novel soluble Fas splice variants.
Wood CM; Goodman PA; Vassilev AO; Uckun FM
Eur J Haematol; 2003 Mar; 70(3):156-71. PubMed ID: 12605660
[TBL] [Abstract][Full Text] [Related]
19. Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells.
Robertson MJ; Manley TJ; Pichert G; Cameron C; Cochran KJ; Levine H; Ritz J
Leuk Lymphoma; 1995 Mar; 17(1-2):51-61. PubMed ID: 7539660
[TBL] [Abstract][Full Text] [Related]
20. Membrane-bound Fas (Apo-1/CD95) ligand on leukemic cells: A mechanism of tumor immune escape in leukemia patients.
Buzyn A; Petit F; Ostankovitch M; Figueiredo S; Varet B; Guillet JG; Ameisen JC; Estaquier J
Blood; 1999 Nov; 94(9):3135-40. PubMed ID: 10556200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
